Skip to content

A pregnancy, reproductive, and birth outcomes cohort based on developmental origins of disease

A pregnancy, reproductive, and birth outcomes cohort based on developmental origins of disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096163
Enrollment
Unknown
Registered
2025-01-20
Start date
2025-01-21
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases, allergies and immunity, brain development and dysfunction, urinary system diseases, etc

Interventions

Healthy population cohort:none
Pregnancy low armour cohort:None
The Geriatric Pregnant Women Cohort:None
Premature Birth Cohort:None
Bidirectional queue:None

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.All assisted reproduction families are accepted; 2.Pregnant women >=38 years of age are accepted; 3.Receiving pregnant women with low A during pregnancy (serum TSH concentration between 4.0 and 10mlU/L); 4.Pregnant fetuses, infants and young children with abnormal results indicated by blood tests and B-ultrasound during pregnancy (including intrauterine growth restriction, abnormal growth and development of various organ systems, etc.); 5.Accept families with multiple children; 6.Preterm infants born before 35 weeks are accepted; 7.Female age >=20 years old, male age >=22 years old, offspring <=3 years old; 8.Neither parent has HIV, other sexually transmitted diseases and other infectious diseases, and there is no family history of hereditary diseases such as Down syndrome; 9.Both parents agreed to participate and cooperate with long-term follow-up; 10.Sign informed consent before the project research, and have a full understanding of the research content, process and possible adverse reactions, and be able to communicate well with researchers.

Exclusion criteria

Exclusion criteria: 1.Participants deemed unsuitable for this trial.

Design outcomes

Primary

MeasureTime frame
Congenital heart disease;anaphylactic disease;Brain development and dysfunction;Urology disease;

Countries

China

Contacts

Public ContactMaoping Chu

The Second Affiliated Hospital of Wenzhou Medical University

chmping@126.com+86 577 8567 6821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026